# Xenetic Biosciences, Inc. (XBIO)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/XBIO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 806.9K | $ -456.4K | $ -536.4K | $ 0 | $ 6.95M |
| 2025 | $ 3.05M | $ -2.74M | $ -2.34M | $ 0 | $ 7.40M |
| 2024 | $ 2.63M | $ -4.16M | $ -2.96M | $ 0 | $ 6.01M |
| 2023 | $ 2.75M | $ -4.47M | $ -4.45M | $ 0 | $ 9.80M |
| 2022 | $ 1.91M | $ -7.32M | $ -5.19M | $ 0 | $ 13.65M |
| 2021 | $ 1.38M | $ -6.71M | $ -5.63M | $ 27.0K | $ 18.39M |
| 2020 | $ 556.6K | $ -13.88M | $ -5.44M | $ 62.5K | $ 12.22M |
| 2019 | $ 22.0K | $ -16.49M | $ -8.26M | $ 20.0K | $ 17.21M |
| 2018 | $ 0 | $ -9.64M | $ -8.54M | $ 0 | $ 9.91M |
| 2017 | $ 10.22M | $ -4.84M | $ 2.00M | $ 0 | $ 14.30M |
| 2016 | $ 4.13M | $ -74.58M | $ -12.11M | $ 0 | $ 16.17M |
| 2015 | $ 0 | $ -17.56M | $ -7.44M | $ 395.0K | $ 6.61M |
| 2014 | $ 0 | $ -20.22M | $ -17.50M | $ 400.0K | $ 10.48M |
| 2013 | $ 94.0K | $ -223.5K | $ 41.0K | $ 372.8K | $ -264.5K |
| 2012 | $ 190.6K | $ -181.9K | $ -1.85M | $ 212.8K | $ -107.4K |
| 2011 | $ 20.2K | $ -26.7K | $ -2.7K | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.14 |
| Current Ratio | 7.93 |

## Other views

- [Metrics](https://sponda.capital/en/XBIO.md)
- [Charts](https://sponda.capital/en/XBIO/charts.md)
- [Compare](https://sponda.capital/en/XBIO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.